Nonnucleoside reverse transcriptase inhibitors

Details Nonnucleoside reverse transcriptase inhibitors Nonnucleoside reverse transcriptase inhibitors

2008-03-25

2008-03-25

Anderson, Rebecca (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S364000, C514S384000

Reexamination Certificate

active

07348345

ABSTRACT:
This invention relates to methods of treating an HIV infection with novel heterocyclic compounds of formula I wherein R1—R4, X1and X2are as defined in the summary and pharmaceutically acceptable salts, and methods to inhibit or modulate Human Immunodeficiency Virus (HIV) reverse transcriptase with compounds of formula I.

REFERENCES:
patent: 3274185 (1966-09-01), Sigal, Jr. et al.
patent: 3813384 (1974-05-01), Vogelsang et al.
patent: 4826990 (1989-05-01), Musser et al.
patent: 4942236 (1990-07-01), Musser et al.
patent: 5103014 (1992-04-01), Musser et al.
patent: 6248769 (2001-06-01), Cavalla et al.
patent: 0 273 309 (1995-01-01), None
patent: 0 273 310 (1995-06-01), None
patent: WO 97/40017 (1997-10-01), None
patent: WO 02/36576 (2002-05-01), None
Graham, B.S., (“Clinical trials of HIV vaccines.” HIV Molecular Immunology Database 2000. Edited by: Korber BT, Brander C, Haynes BF, Koup R, Kuiken C, Moore JP, Walker BD, and Watkins D. Published by: Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, pp. 1-20-38.
Rosen, Gerald M., et al., “2-Benzyl-1,3,4-oxadiazolin-5-one and Related Compounds,”Notes, Dept. of Chemistry, Clarkson College of Technology, Potsdam, NY, Aug. 1971, pp. 659-662.
De Clercq, Erik, “New Developments in Anti-HIV Chemotherapy,”Current Medicinal Chemistry, 2001, pp. 1543-1572, vol. 8, No. 13, Bentham Science Publishers Ltd.
Buckheit, Jr., Robert W., Non-nucleoside reverse transcriptase inhibitors: perspectives on novel therapeutic compounds and strategies for the treatment of HIV infection,Expert Opinion,.Investigative Drugs, Ashley Publications, Ltd., 2001, pp. 1423-1442, vol. 10, No. 8.
Del Elmo, Esther, et al., “Anti-Trypanosoma Activity of Some Natural Stilbenoids and Synthetic Related Heterocyclic Compounds”,Bioorganic&Medicinal Chemistry Letters, 2001, pp. 2755-2757, No. 11.
Del Elmo, Esther, et al., “Leishmanicidal Activity of Some Stilbenoids and Related Heterocyclic Compounds,”Bioorganic&Medicinal Chemistry Letters, 2001, pp. 2123-2126, No. 11.

Affiliated with

Also associated with

Rating

Nonnucleoside reverse transcriptase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nonnucleoside reverse transcriptase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nonnucleoside reverse transcriptase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2785895